Manage Your Operations With DSCP for Life Sciences
The global Life Sciences industry is in the midst of unprecedented change. Tightening global regulations, historic healthcare reform and an increasing merger and acquisitions activity force Life Sciences manufacturers to change the way they go to market and manage supply chains, operations and distribution. To remain competitive and profitable, Life Sciences manufacturers must create additional value by controlling logistics costs, improving forecast reliability and reducing cycle time from R&D through delivery.
The supply chains for life science manufacturers grow more complex each year. New market opportunities and increased M&A activity are making device supply chains longer and more difficult to manage, while track and trace regulations around the world require greater visibility and control.
Empowering Life Sciences Companies
QAD DynaSys Demand and Supply Chain Planning (DSCP) for Life Sciences is integrated, flexible, enables enhanced planning and optimization of complex global supply chains and improves supply chain visibility and governance.
Benefits for Life Sciences Companies
- Improves customer service with shorter delivery times, fewer stock-outs, improved product availability and quick reaction to demand changes
- Increases margins with cost reduction in distribution and procurement, reduces stockholding and lost sales, and less obsolescence and logistic capacity requirements
- Improves efficiency with greater supply chain visibility, internal and external collaboration, and anticipate procurement requirements while maintaining the overall control of the supply chain
- And More...
Life Sciences Customers
The history of Groupe Batteur started in 1958 when Jacques Batteur, a pharmacist from Lille who already set-up shop in the Paris area, bought Laboratoires Gilbert. In 1986, under the leadership of his son, Laurent Batteur, Groupe Batteur began a period of rapid expansion. During the 30 years that he spent as the head of Groupe Batteur, the workforce grew from 20 employees to more than 900, and the turnover went from €400,000 to €187M. Today, Groupe Batteur manufactures and distributes more than 3000 references from 60 brands over 5 major divisions: Natural Health, Family Medication, Cosmetic, Baby Care and Wholesale. Their distribution is managed by 24 commercial networks over 87 countries with 60% of the revenue being generated in France.
Expanscience is an independent pharmaceutical and dermo-cosmetics laboratory which generated turnover of €272.3 million in 2015, with 51.3 percent coming from international sales. Expanscience employs 977 people. For more than 60 years, the company has earned an international reputation for its professionalism, innovation, and expertise in skin care and in the treatment of arthritis. Its products include two leading brands, Piascledine 300 and Mustela, which are sold in 99 countries (85 countries distributing our products and 14 affiliates). Expanscience also develops and sells active ingredients of natural origin intended for the cosmetics industry in France and internationally. The company incorporates the full value chain, from research to production to distribution. Its CSR policy, in place for 10 years, was acclaimed as being exemplary by Afaq 26000 in 2013.
Curium was formed through the union of IBA Molecular and Mallinckrodt Nuclear Medicine LLC and is a world-class nuclear medicine solutions provider with over 100 years of industry experience. They service over 14 million patients worldwide each year and strive to provide best-in-class products and exceptional, reliable service.
Shiseido was founded in 1872 in Ginza, Tokyo, as the first Western-style pharmacy in Japan. The name Shiseido incorporates the founder’s desire to discover and create new value, a desire that has endured for more than 140 years and has built their unique heritage. This heritage has led to a foundation and strengths unique to Shiseido that are key to their successful evolution going forward. Shiseido owns more than ten brands and lines with sales ranging from 10 to 50 billion yen. Each individual line has nurtured its unique values and they keep growing to be the brands deeply loved by people from all over the world.
“With the implementation of the QAD DynaSys DSCP solution we save time and achieve a better reactivity facing events on the markets, thus enabling a control of stocks and their decrease”
S&OP Referencial Supervisor – Essilor
“QAD DynaSys gives our Supply Chain team an opportunity to optimize its processes while enabling the IT team to standardize its information system with a reliable and robust cloud based solution.”
CIO – Laboratoires Expanscience
Contact our highly trained experts to get more information about QAD DynaSys DSCP for life sciences.